References
- Claeys MJ, Bosman J, Veenstra L, Jorens P, De RaedtH, Vrints CJ. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: Importance of microvascular reperfusion injury on clinical outcome. Circulation 1999;99:1972–7.
- Deibele AJ, Jennings LK, Tcheng JE, Neva C, Earhart AD, Gibson CM. Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: The intracoronary eptifibatide (ICE) trial. Circulation 2010;121:784–91.
- Goto S, Tamura N, Ishida H. Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions. J Am Coll Cardiol. 2004;44: 316–23.
- Gibson CM, Zorkun C, Kunadian V. Intracoronary administration of abciximab in ST-elevation myocardial infarction. Circulation 2008;118:6–8.
- Pinto DS, Kirtane AJ, Ruocco NA, Deibele AJ, Shui A, Buros J, . Administration of intracoronary eptifibatide during ST-elevation myocardial infarction. Am J Cardiol 2005;96:1494–7.